advertising
-
1.
Hambleton P. & Moore AP. “Botulinum Neurotoxins: Origin, Structure, Molecular Actions and Antibodies,” in Handbook of Botulinum Toxin Treatment , edited by Moore, AP p 16, Blackwell Science Ltd, Oxford, England, 1995.
-
2.
Simpson LL. “Current Concepts on the Mechanism of Action of Clostridial Neurotoxins,” in Botulinum and Tetanus Neurotoxins , edited by Das Gupta, BR p 5, Plenum Press, New York, 1993.
-
3.
Biglan AW. , Burnstine RA. & Rogers GL. et al.: Management of strabismus with botulinum toxin A. Ophthalmology 96: 935, 1989.
-
4.
Suputtitada A. Local botulinum toxin type A injections in the treatment of spastic toes. Am J Phys Med Rehabil 81: 770, 2002.
-
5.
Tamura BM. , Cuce LC. & Souza RL. et al.: Plantar hyperhidrosis and pitted keratolysis treated with botulinum toxin injection. Dermatol Surg 30: 1510, 2004.
-
6.
Babcock MS. , Foster L. & Pasquina P. et al.: Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil 84: 649, 2005.
-
7.
Radovic P. & Shah E. Nonsurgical treatment for hallux abducto valgus with botulinum toxin. JAPMA 98: A1, 2008.
-
8.
Wu KP. , Chen CK. & Lin SC. et al.: Botulinum toxin type A injections for patients with painful hallux valgus: a double-blind, randomized controlled study. Clin Neurol Neurosurg 129 (suppl 1) : S58, 2015.
-
9.
Tang, , Chen JT. , Chen CK. et al: Effective conservative treatment for managing painful hallux valgus. Med Res Arch 4: October 2016. Available at https://journals.ke-i.org/mra/article/view/685. Accessed March 10, 2020.
-
10.
Moghtaderi A. , Dehghan F. & Mousavizadeh A. et al.: Evaluation of the therapeutic effect of botulinum toxin A on hallux valgus deformity and pain. Int J Phys Med Rehabil 5: 438, 2017.
-
11.
Bhidayasiri R. & Truong DD. Expanding use of botulinum toxin. J Neurol Sci 235: 1, 2005.
-
12.
Placzek R. , Sohling M. & Gessler M. et al.: Botulinum toxin A in orthopedic pain therapy. Schmerz 18: 498, 2004.
-
13.
Aoki KR. Evidence for antinociceptive activity for botulinum toxin type A in pain management. Headache 43 (suppl 1) : S9, 2003.
-
14.
Arinci I. , Genc H. & Erdem HR. et al.: Muscle imbalance in hallux valgus: an electromyographic study. Am J Phys Med Rehabil 82: 345, 2003.
-
15.
Hoffmeyer P. , Cox JN. & Blanc Y. et al.: Muscle in hallux valgus. Clin Orthop Relat Res 232: 112, 1988.
-
16.
Coughlin MJ. , Mann RA. , Saltzman CL : Surgery of the Foot and Ankle , 8th Ed, Mosby Elsevier, Philadelphia, PA, 2007.
-
17.
Sherman A. , Willick S. & Cardenas D. Management of focal dystonia of extensor hallucis longus muscle with botulinum toxin injection: a case report. Arch Phys Med Rehabil 79: 1303, 1998.
Nonsurgical Treatment for Hallux Abducto Valgus with Botulinum Toxin Type A
An Improvement of the Injection Paradigm
Search for other papers by Philip Andrew Radovic in
Current site
Google Scholar
PubMed
Background
Hallux abducto valgus (HAV) is a frequently seen abnormality of the first metatarsophalangeal joint. Limited conservative treatment options exist, making surgery the only definitive treatment option for a mild to moderate deformity. Since initially published in 2008, treatment of HAV with botulinum toxin injection has evolved as a potentially effective modality as shown in several subsequent independent studies.
Methods
Botulinum injection of two intrinsic foot muscles (extensor halluces brevis and flexor hallucis brevis) in addition to adductor hallucis under electrical stimulation is presented as an improvement to the original method.
Results
The additional muscle injections of botulinum resulted in an further reduction of the HAV deformity and associated pain.
Conclusions
A significant improvement to the injection paradigm developed the author may prove to be more effective in reducing the HAV deformity and its associated pain.
advertising
